Marc S Sabatine

49PUBLICATIONS
252CO-AUTHORS
Cardiology (incl. cardiovascular diseases)Predictive and prognostic markersCardiovascular medicine and haematology not elsewhere classifiedMolecular targetsProteins and peptides
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (49)

|Aug 31, 2026
Effects of Evolocumab on Mortality Outcomes in Patients Without Previous Myocardial Infarction or Stroke: A Prespecified Analysis of the VESALIUS-CV Randomized Clinical Trial.

|Jun 03, 2026
Safety of low lipoprotein(a) levels: the FOURIER trial.

|May 29, 2026
Prior anticoagulation experience and bleeding risk with the factor XI inhibitor abelacimab in the AZALEA-TIMI 71 study.

|May 25, 2026
Lipoprotein(a) Levels, Risk of Cardiovascular Events, and Benefit of Evolocumab: Findings From the VESALIUS-CV Trial.

|May 19, 2026
Evolocumab in Patients With Prior Percutaneous Coronary Intervention and No Prior Myocardial Infarction: Results From the VESALIUS-CV Trial.

|Mar 30, 2026
Effect of APOC3 Inhibition With Olezarsen on Coronary Atherosclerosis: Essence-TIMI 73b Imaging Study.

Nicholas A Marston, Brian A Bergmark, Thomas A Prohaska

Pageof 9

Frequent Collaborators

13 joint publications

Robert P Giugliano

12 joint publications

Michelle L O'Donoghue

10 joint publications

John J V McMurray

10 joint publications

Sabina A Murphy